SARS-CoV-2 Breakthrough Infections According to the Immune Response Elicited after mRNA Third Dose Vaccination in COVID-19-Naïve Hospital Personnel

Background: Vaccine-induced SARS-CoV-2-anti-spike antibody (anti-S/RBD) titers are often used as a marker of immune protection and to anticipate the risk of breakthrough infections, although no clear cut-off is available. We describe the incidence of SARS-CoV-2 vaccine breakthrough infections in COV...

Descripción completa

Detalles Bibliográficos
Autores principales: Santoro, Annapaola, Capri, Andrea, Petrone, Daniele, Colavita, Francesca, Meschi, Silvia, Matusali, Giulia, Mizzoni, Klizia, Notari, Stefania, Agrati, Chiara, Goletti, Delia, Pezzotti, Patrizio, Puro, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215853/
https://www.ncbi.nlm.nih.gov/pubmed/37238918
http://dx.doi.org/10.3390/biomedicines11051247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215853/
https://www.ncbi.nlm.nih.gov/pubmed/37238918
http://dx.doi.org/10.3390/biomedicines11051247

Ejemplares similares